• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然存在的人免疫球蛋白 G1 和 G2 的聚糖形式。

Naturally occurring glycan forms of human immunoglobulins G1 and G2.

机构信息

Department of Process and Product Development, Amgen Inc., Thousand Oaks, CA 91320, USA.

出版信息

Mol Immunol. 2010 Jul;47(11-12):2074-82. doi: 10.1016/j.molimm.2010.04.006. Epub 2010 May 4.

DOI:10.1016/j.molimm.2010.04.006
PMID:20444501
Abstract

High resolution glycan mapping was performed on human immunoglobulin G (IgG) obtained from individual healthy subjects and from a combined sample of healthy subjects. In addition to the commonly known complex glycans, a variety of minor glycans are described and quantified, including high mannose forms and several previously unreported hybrid forms. Fc specific glycan analysis was also performed through peptide mapping with LC/MS/MS. Differences in the glycan linked Fc peptide masses allowed glycan profiles to be analyzed and quantified from IgG1 and IgG2 simultaneously for each subject within the same sample. Glycan profiles differed between subtypes, with greater levels of more fully galactosylated species found on IgG1 (e.g. G2F, SG2F) than IgG2. These results also show that Gal attachment on G1F is biased to the Man (alpha1-->6) arm for IgG1 and on the Man (alpha1-->3) arm for IgG2 from individual healthy subjects.

摘要

对来自个体健康受试者和健康受试者混合样本的人免疫球蛋白 G(IgG)进行了高分辨率聚糖图谱分析。除了常见的复杂聚糖外,还描述和定量了多种少量聚糖,包括高甘露糖形式和几种以前未报道的杂合形式。通过 LC/MS/MS 的肽图谱分析也进行了 Fc 特异性聚糖分析。连接 Fc 的聚糖肽质量的差异允许对同一样本中每个受试者的 IgG1 和 IgG2 同时进行聚糖谱分析和定量。聚糖谱在亚型之间存在差异,在 IgG1(例如 G2F、SG2F)上发现了更多完全半乳糖化的物种,其水平高于 IgG2。这些结果还表明,Gal 附着在 IgG1 的 Man(alpha1-->6)臂上和 IgG2 的 Man(alpha1-->3)臂上偏向于个体健康受试者。

相似文献

1
Naturally occurring glycan forms of human immunoglobulins G1 and G2.天然存在的人免疫球蛋白 G1 和 G2 的聚糖形式。
Mol Immunol. 2010 Jul;47(11-12):2074-82. doi: 10.1016/j.molimm.2010.04.006. Epub 2010 May 4.
2
Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.通过电喷雾电离质谱法研究人IgG蛋白的Fab和Fc之间的糖基化谱差异。
J Immunol Methods. 2007 Sep 30;326(1-2):116-26. doi: 10.1016/j.jim.2007.07.014. Epub 2007 Aug 8.
3
Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.免疫球蛋白G中寡糖-蛋白质相互作用的变化决定了位点特异性糖基化谱,并调节Fc寡糖的动态运动。
Biochemistry. 1997 Feb 11;36(6):1370-80. doi: 10.1021/bi9621472.
4
Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.正常人类血浆来源免疫球蛋白及其片段 Fab 和 Fc 的定量糖基化分析。
J Immunol Methods. 2012 Aug 31;382(1-2):167-76. doi: 10.1016/j.jim.2012.05.022. Epub 2012 Jun 6.
5
A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.通过电喷雾和基质辅助激光解吸/电离质谱法对单克隆和多克隆物种中的免疫球蛋白G糖基化进行的研究。
Anal Biochem. 2002 Jun 1;305(1):16-31. doi: 10.1006/abio.2002.5651.
6
High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.治疗性 IgG 抗体 Fc 区域上的高甘露糖聚糖会增加人体血清清除率。
Glycobiology. 2011 Jul;21(7):949-59. doi: 10.1093/glycob/cwr027. Epub 2011 Mar 18.
7
The effect of Fc glycan forms on human IgG2 antibody clearance in humans.Fc聚糖形式对人IgG2抗体在人体内清除率的影响。
Glycobiology. 2009 Mar;19(3):240-9. doi: 10.1093/glycob/cwn120. Epub 2008 Oct 30.
8
Analysis of N-glycans from recombinant immunoglobulin G by on-line reversed-phase high-performance liquid chromatography/mass spectrometry.通过在线反相高效液相色谱/质谱法分析重组免疫球蛋白G的N-聚糖。
Anal Biochem. 2007 Nov 15;370(2):147-61. doi: 10.1016/j.ab.2007.08.012. Epub 2007 Aug 14.
9
Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase.牛溶酶体α-甘露糖苷酶的位点特异性糖基化分析
Glycobiology. 2006 May;16(5):440-61. doi: 10.1093/glycob/cwj081. Epub 2006 Jan 31.
10
IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.抗环瓜氨酸肽IgG抗体在IgG亚类、Fc聚糖和Fab-肽序列方面呈现出特定的特征。
PLoS One. 2014 Nov 26;9(11):e113924. doi: 10.1371/journal.pone.0113924. eCollection 2014.

引用本文的文献

1
Efficacy, safety, and immunogenicity of biosimilars compared with the biologic etanercept in patients with rheumatoid arthritis: a systematic review and meta-analysis.比较生物类似药与依那西普生物制剂在类风湿关节炎患者中的疗效、安全性和免疫原性:系统评价和荟萃分析。
Syst Rev. 2024 Nov 27;13(1):291. doi: 10.1186/s13643-024-02715-w.
2
Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement.感染过程中的Fc-FcγR相互作用:从中和抗体到抗体依赖增强作用
Immunol Rev. 2024 Nov;328(1):221-242. doi: 10.1111/imr.13393. Epub 2024 Sep 13.
3
The role of antibody glycosylation in autoimmune and alloimmune kidney diseases.
抗体糖基化在自身免疫和同种免疫性肾脏疾病中的作用。
Nat Rev Nephrol. 2024 Oct;20(10):672-689. doi: 10.1038/s41581-024-00850-0. Epub 2024 Jul 3.
4
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.血清免疫球蛋白和 Fc 受体介导的免疫激活阈值。
Biochim Biophys Acta Gen Subj. 2023 Nov;1867(11):130448. doi: 10.1016/j.bbagen.2023.130448. Epub 2023 Aug 29.
5
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab.贝伐珠单抗生物类似药 BAT1706 与参比制剂的理化性质和功能相似性评估。
Drugs R D. 2023 Sep;23(3):267-288. doi: 10.1007/s40268-023-00432-8. Epub 2023 Jul 22.
6
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.糖基化影响多种蛋白、基因和细胞治疗的疗效和安全性。
Biotechnol Adv. 2023 Oct;67:108206. doi: 10.1016/j.biotechadv.2023.108206. Epub 2023 Jun 22.
7
Production of recombinant human IgG1 Fc with beneficial N-glycosylation pattern for anti-inflammatory activity using genome-edited chickens.利用基因编辑鸡生产具有抗炎活性的有益 N-糖型重组人 IgG1 Fc。
Commun Biol. 2023 Jun 1;6(1):589. doi: 10.1038/s42003-023-04937-5.
8
Integrated summary of immunogenicity of polatuzumab vedotin in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.在复发或难治性 B 细胞非霍奇金淋巴瘤患者中,帕洛昔单抗维地滨的免疫原性综合总结。
Front Immunol. 2023 Mar 29;14:1119510. doi: 10.3389/fimmu.2023.1119510. eCollection 2023.
9
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants.重组单克隆抗体电荷变体的基于风险的控制策略
Antibodies (Basel). 2022 Nov 20;11(4):73. doi: 10.3390/antib11040073.
10
Challenges and Strategies for a Thorough Characterization of Antibody Acidic Charge Variants.全面表征抗体酸性电荷变体的挑战与策略
Bioengineering (Basel). 2022 Nov 3;9(11):641. doi: 10.3390/bioengineering9110641.